URGN UroGen Pharma Ltd
- 12.700
- +0.320+2.58%
- 12.700
- 0.0000.00%
UroGen Pharma Ltd News
UroGen Pharma Ltd | 8-K: Current report
UroGen Pharma Ltd | 8-K: Current report
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Schoenberg Mark
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Smith Jason Drew
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Officer Kim Dong
UroGen Pharma Ltd | 144: Notice of proposed sale of securities pursuant to Rule 144
UroGen Pharma Ltd | 8-K: Current report
UroGen Pharma Ltd | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
UroGen Pharma Ltd | 10-Q: Q2 2024 Earnings Report
UroGen Pharma Ltd | 8-K: UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights
UroGen Pharma Ltd | 8-K: Current report
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Belldegrun Arie
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Cohen Fred E
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Wildman Daniel George
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Holden Stuart
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director Robinson James A. Jr.
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director WEN LEANA
UroGen Pharma Ltd | 4: Statement of changes in beneficial ownership of securities-Director BUTITTA CYNTHIA M
UroGen Pharma Ltd | ARS: Annual Report to Security Holders
UroGen Pharma Ltd | DEF 14A: Definitive information statements
Analysis
Price Target
No Data
No Data